// App-Quantinova.ai

PB0947 : UK EHL Registry: Patient Reported Outcomes Measured by Haemoprefer Patient Treatment Preference and Perception Tool

Researchers

Presenter

  • P. Chowdary

Principal Investigators

  • Z. Hanif

  • N. Chadwick

  • C. Tait

  • M. Mathias

  • S. Mangles

  • G. Evans

  • B. Myers

  • D. Beech

  • M. Makris

  • K. Talks

  • S. Austin

  • P. Collins

  • E. Chalmers

  • E. Phillips

  • J. Motwani

  • G. Dolan

  • C. Hay

  • D. Hart

Medical Centers

  • KD Haemophilia Centre and Thrombosis Unit, Haemophilia, London, United Kingdom

  • Oxford University Hospital NHS Foundation Trust, Haemophilia & Thrombosis, Oxford, United Kingdom

  • KD Haemophilia Centre and Thrombosis Unit, Haemophilia, London, United Kingdom

  • Glasgow Royal Infirmary, Gastroenterology Unit, Glasgow, United Kingdom

  • Great Ormond Street Hospital, London, United Kingdom

  • Hampshire Hospital, Basingstoke and North Hampshire Hospital, Haemophilia, Winchester, United Kingdom

  • Kent & Canterbury Hospital, Haemophilia, Canterbury, United Kingdom

  • Lincoln County Hospital NHS Trust, Haemophilia, Lincolnshire, United Kingdom

  • Royal Cornwall Hospital, Haemophilia, Cornwall, United Kingdom

  • Royal Hallamshire Hospital, Sheffield, United Kingdom

  • Royal Victoria Infirmary, Newcastle, United Kingdom

  • St. George's University Hospital, London, United Kingdom

  • University Hospital of Wales, Cardiff, United Kingdom

  • Glasgow Royal Hospital for Children, Haemophilia, Govan, United Kingdom

  • University of Bristol, Bristol, United Kingdom

  • Birmingham Women's and Children's NHS Foundation Trust, Diabetes Home Care Unit, Birmingham, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Manchester Royal Infirmary, Manchester, United Kingdom

  • Royal London Hospital, Haemophilia, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Protein Tyrosine Phosphatase, Non-Receptor Type 11

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved